Gastrointestinal and Hepatobiliary Complications of Extensively Drug-Resistant Typhoid at a Tertiary Care Hospital in Pakistan

Abstract

Introduction: Typhoid fever is a major health problem in developing countries. Extensively drug-resistant (XDR) typhoid is an emerging threat to world health. The objectives of this study were to report our blood culture proven patients having XDR typhoid and compare the rate of gastrointestinal (GI) and hepatobiliary manifestations and complications of antimicrobial sensitive and resistant strains. Materials and methods: This prospective observational study was carried out at a tertiary care hospital in Pakistan, from January 2019 till August 2020 on all consecutive blood culture proven patients of Salmonella typhi. A total of 57 cases of Salmonella were identified, of which 10 were nonresistant, seven multi drugresistant (MDR), 39 extensively drug-resistant (XDR), and one was extended-spectrum beta lactamase (ESBL) positive. Alarmingly, one of the S. typhi isolate in addition to the first line drugs, was also resistant to azithromycin. Patients were treated with antibiotics according to antimicrobial susceptibility of the Salmonella in accordance with the World Health Organization (WHO) and Medical Microbiology and Infectious Diseases Society of Pakistan (MMIDSP) guidelines and GI and hepatobiliary complications were recorded. Results: Overall rate of complications was low. Some 10% (1/10) with nonresistant typhoid, 14% (1/7) with MDR, and 15% (6/39) of our patients with XDR typhoid fever had abdominal tenderness (p=0.95). None of the patients had GI bleeding, abdominal abscess, or peritonitis. Some 20% (2/10) patients with nonresistant typhoid, 29% (2/7) with MDR, and 18% (7/39) with XDR typhoid developed acute hepatitis, with greater than three times elevation of liver transaminases. There was no statistically significant difference in the occurrence of hepatitis between these groups (p=0.98). Interestingly, one of our patients with XDR typhoid also developed cholestatic hepatitis. Conclusion: There is no significant difference in GI and hepatobiliary complications amongst antimicrobial sensitive and resistant strains of typhoid. However, emergence of resistant strains calls for focus on prevention and judicious use of antimicrobials.

Traditional Widal Agglutination Test Versus Rapid Immunochromatographic Test in the Diagnosis of Enteric Fever: A Prospective Study From South India

“…The drawback of low PPV includes false-positive diagnosis and unnecessary antibiotic therapy [15]. This could further put a financial burden on the patients and be responsible for the emergence of multi-drug resistance and further limit treatment options [16][17][18][19][20][21].…”

Fatal Complications of Extensive Drug-Resistant Typhoid Fever: A Case Report

“…Our patient was noted to have jaundice and hepato-splenomegaly upon physical examination which was then confirmed on ultrasound imaging. These findings could be explained by the proliferation of the reticuloendothelial cells during the pathogenesis of the disease [ 11 ]. Hepatomegaly can be found in up to 18% of the cases of XDR disease, while splenomegaly is noted to be a common presentation in up to 41% of XDR cases [ 11 ].…”

“…These findings could be explained by the proliferation of the reticuloendothelial cells during the pathogenesis of the disease [ 11 ]. Hepatomegaly can be found in up to 18% of the cases of XDR disease, while splenomegaly is noted to be a common presentation in up to 41% of XDR cases [ 11 ]. Deranged liver function tests could indicate underlying salmonella hepatitis, a rare complication of typhoid fever.…”

Extensive Drug-Resistant Typhoid Fever Prevention and Management in Pakistan: A Challenge to Public Health

“…Nevertheless, XDR-typhoid is becoming more resistant to the administration of azithromycin, according to recent investigations. 22 As a result of this, physicians are being forced to inject both tigecycline and carbapenem, which are typically reserved as the last-resort treatment for typhoid fever. Due to their high cost and relative inaccessibility totheimpoverishedpopulationindevelopingnations,manyofthesemedicationsrequirein-patienttreatment.…”